Carbidopa
Carbidopa, found in Sinemet and Stalevo, is used alongside levodopa for movement symptoms of Parkinson’s disease. This catalogue lists these two combination tablets.
Key points
- Carbidopa is a decarboxylase inhibitor that reduces levodopa breakdown before it reaches the brain.
- This can allow levodopa to address dopamine-related movement symptoms with less nausea and vomiting outside the brain.
- Stopping suddenly can cause a serious syndrome with fever, rigidity, unusual movements and confusion.
Brands and forms in this catalogue
Both entries are tablets in Neurology. Sinemet contains carbidopa and levodopa, while Stalevo also contains entacapone. They are listed for Parkinson’s Disease, and Sinemet is also listed for Parkinsonism.